| Literature DB >> 26804338 |
Hardy Hagena1, Niels Hansen1, Denise Manahan-Vaughan1.
Abstract
Noradrenaline (NA) is a key neuromodulator for the regulation of behavioral state and cognition. It supports learning by increasing arousal and vigilance, whereby new experiences are "earmarked" for encoding. Within the hippocampus, experience-dependent information storage occurs by means of synaptic plasticity. Furthermore, novel spatial, contextual, or associative learning drives changes in synaptic strength, reflected by the strengthening of long-term potentiation (LTP) or long-term depression (LTD). NA acting on β-adrenergic receptors (β-AR) is a key determinant as to whether new experiences result in persistent hippocampal synaptic plasticity. This can even dictate the direction of change of synaptic strength.The different hippocampal subfields play different roles in encoding components of a spatial representation through LTP and LTD. Strikingly, the sensitivity of synaptic plasticity in these subfields to β-adrenergic control is very distinct (dentate gyrus > CA3 > CA1). Moreover, NA released from the locus coeruleus that acts on β-AR leads to hippocampal LTD and an enhancement of LTD-related memory processing. We propose that NA acting on hippocampal β-AR, that is graded according to the novelty or saliency of the experience, determines the content and persistency of synaptic information storage in the hippocampal subfields and therefore of spatial memories.Entities:
Keywords: hippocampus; memory; noradrenaline; synaptic plasticity; β-adrenergic receptors
Mesh:
Substances:
Year: 2016 PMID: 26804338 PMCID: PMC4785955 DOI: 10.1093/cercor/bhv330
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357
Figure 1.Summary of the different signaling pathways that respond to activation of β1AR (blue) and β2AR (green). PKA phosphorylation mediates the switch from Gα to Gβ activation (dotted blue line). An inhibitory effect resulting from β-arrestin and PDE4 action is shown by the red dotted line. AC, adenylate cyclase; PI3K, phosphatidylinositol 3-kinase; ATP, adenosine triphosphate; B-Raf, proto-oncogene B-Raf; cAMP, 3′-5′-cyclic adenosine monophosphate; C-Raf, RAF proto-oncogene serine/threonine kinase; CREB, cAMP-responsive element-binding protein; ERK, extracellular signal-regulated kinase; Gαs, Gαi, Gβɣ, G-proteins; GRK, G protein-coupled receptor kinase; MAPK, mitogen-activated protein kinase; MEK, mitogen-activated protein kinase; NE, norepinephrine; PDE4, phosphodiesterase-4; PKA, protein kinase; RAS, membrane-associated guanine nucleotide-binding protein; Src, proto-oncogene tyrosine-protein kinase; SOS, Son of Sevenless, genes encoding guanine nucleotide exchange factors (Winder et al. 1999; Schmitt and Stork 2000; Xiao 2001; Lefkowitz et al. 2002; Baillie et al. 2003; Shenoy et al. 2006; Lemon et al. 2009; Meitzen et al. 2011).
Figure 2.Noradrenergic projections of the locus coeruleus involved in the modulation of persistent hippocampal synaptic plasticity in the rat brain. The locus coeruleus (LC) sends projections to the basolateral amygdala (BLA), thalamus (Thal), orbitofrontal cortex (OFC), frontal cortex (FC), anterior cingulate cortex (ACC), Cortex (Cx), and hippocampus (Hipp). The projection to the hippocampus is responsible for modulating hippocampal synaptic plasticity (Harley 2007; Lemon et al. 2009; Sara 2009; Lemon and Manahan-Vaughan 2012). The DG receives the strongest noradrenergic projection from the LC (indicated by the big black arrow in the magnification of the hippocampus on the upper right side) compared with CA1 and CA3 (smaller black arrows indicate weaker LC projections) (Loy et al. 1980; Fallon and Loughlin 1982) underpinning its role in novelty gating within hippocampal information processing. Electrical activation of the LC induces β-AR-dependent long-term depression in SC-CA1 and DG synapses (Lemon et al. 2009; Hansen and Manahan-Vaughan 2015b) indicating the important role of the LC in encoding novel information. In addition, the different stages of memory are dependent on a complex interaction within this noradrenaline (NA)–LC network. Memory consolidation is promoted by the Hipp and BLA (Eichenbaum 2000; Roozendaal et al. 2008), whereas memory retrieval is enabled by an interaction between the Hipp and FC (Corbetta and Shulman 2002; Sara 2010). The projection from the FC and ACC to the LC is believed to contribute to the reconsolidation of memory processes (Sara 2000, 2009, 2010). The FC regulates the control of attention to a novel or salient stimulus (Corbetta et al. 2008; Robbins and Arnsten 2009). According to the integrative theory of NA-LC function, the OFC and ACC send projections to the LC, driving transitions between the LC modes and phasic LC responses to adapt synaptic gain (Aston-Jones and Cohen 2005).
Effects of β-AR antagonists and agonists on synaptic plasticity in vitro
| Drug/knockout | Subtype | Subregion | Effect on plasticity | References |
|---|---|---|---|---|
| Isoproterenol | β1, β2 | CA1 | Induction of LTP (>40 min) | |
| Blocks depotentiation | ||||
| STP strengthened | ||||
| No effect on LTP (>2 h) | ||||
| Enhances E-LTP and L-LTP | ||||
| Induction of TPS-LTP (1 h) | ||||
| Induction of TPS-LTP (30 min) | ||||
| Enhances induction of LTP | ||||
| LTP enhanced | ||||
| LTP after low-frequency stimulation | ||||
| LTP induction enhanced | ||||
| LTP enhanced (1 h) | ||||
| LTD blocked | ||||
| No effect on NA-induced LTP | ||||
| LTP enhanced (1 h) | ||||
| CA3 | STP strengthened | |||
| No effect on LTP | ||||
| Propranolol | β1, β2 | DG | Blocked LTP in LPP and MPP | |
| CA1 | No effect on LTP (>3 h) | |||
| Dose-dependently blocks LTP | ||||
| LTP blocked | ||||
| CA3 | Blocks E-LTP and L-LTP | |||
| LTP (3 h) blocked | ||||
| R(AB) + Isoproterenol | CA1 | LTP enhanced | ||
| β1, β2 | β1, β2 | CA1 | LTP impaired |
Effects of β-AR antagonists and agonists on synaptic plasticity in vivo
| Drug/knockout | Subtype | Subregion | Effect on plasticity | References |
|---|---|---|---|---|
| Isoproterenol | β1, β2 | CA1 | No effect on LTP (>24 h), STP and LTD (>24 h) | |
| STD strengthened | ||||
| STP strengthened | ||||
| No effect on learning-facilitated | ||||
| LTD | ||||
| CA3 | STP strengthened | |||
| DG | STP strengthened | |||
| STD strengthened | ||||
| Propranolol | β1, β2 | CA1 | LTP (>24 h) blocked | |
| LTD (>24 h) no effect | ||||
| STD no effect | ||||
| Learning-facilitated LTP blocked | ||||
| Learning-facilitated LTD blocked | ||||
| CA3 | No effect on LTP (>24 h), STP, LTD (>24 h) and STD | |||
| Learning-facilitated LTP blocked | ||||
| Learning-facilitated LTD blocked | ||||
| DG | No effect on LTP | |||
| LTP blocked | ||||
| LTD (>24 h) blocked | ||||
| Learning-facilitated LTP blocked |